Czechia
Limited availability · 12.08.2026
Supply shortage: Tamoxifen 10 mg und 20 mg
Affected country: Czechia · Reported period: 04.08.2026 – not specified · Active ingredient: Tamoxifen
CountryCzechia
PZNnicht angegeben
ENRnicht angegeben
Notification typeLimited availability
Start04.08.2026
Expected endnot specified
Last update12.08.2026
ReasonLimited market availability
ATCL02BA01
Hospital-relevantNo
Notice context
A supply shortage has been recorded for Tamoxifen 10 mg und 20 mg in Czechia. The stated reason is “Limited market availability”. The notice concerns the active ingredient Tamoxifen and is not identified as hospital-relevant.
This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.
Primary source: SÚKL
Official shortage notice for Czechia. Responsibility and update procedures follow the information supplied by the relevant authority.
Check the official notice list →